Tuesday, December 5, 2023
This activity was developed for psychiatrists involved in the care of patients with ADHD.
Attention deficit hyperactivity disorder (ADHD) is the most common psychiatric disorder of childhood and one that frequently persists into adulthood. Research has demonstrated that persistence of ADHD from childhood into adulthood is estimated to be between 50% and 80%, meaning that approximately 4% of the adult population has ADHD. There are currently no formal guidelines or standards of care for adolescent into adulthood ADHD patients. Identifying patients in this population remains a challenge for clinicians. If the ADHD was not recognized when the patient was a child, the diagnosis of ADHD is often overlooked in the adolescent into adulthood period. Diagnosis remains clinically based, relying on clinical interviews, symptom rating scales, and subjective reporting from patients, parents, or siblings. Current diagnostic criteria for ADHD are still based on observations of school-aged children. As a result, the DSM-IV criteria have certain limitations when applied to adolescent into adulthood patients. Furthermore, the existence of comorbid conditions is very common in ADHD, affecting up to 3 of every 4 patients. As a result, psychiatrists must typically evaluate for ADHD amidst other psychiatric disorders. Mood disorders (major depression, bipolar disorder, and dysthymia), anxiety disorders, substance abuse, personality disorders, antisocial behavior, and learning disabilities are the chief psychiatric comorbidities. Continued controversies surrounding the use of psychostimulants in the treatment of ADHD have added to misconceptions and confusion within the community. Because of the unique challenges associated with ADHD in adolescent into adulthood patients, there is a clear need for education on management and treatment strategies for these populations so that psychiatrists may confidently and effectively improve the quality of life for patient with ADHD.
Upon completion of this activity, participants should be able to:
Authors and Disclosures
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), SynerMed® and McNeil Pediatrics do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, SynerMed® and McNeil Pediatrics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty and planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine (PIM) and SynerMed® Communications. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated time to complete activity: 1 hour
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
processing....
